BACKGROUND: Craniopharyngiomas are rare epithelial tumors that are presumed to arise from the remnants of Rathke's pouch. OBJECTIVE: This study was designed to evaluate the outcome characteristics of craniopharyngiomas treated in a single institution and to determine whether the adamantinomatous craniopharyngioma should be considered more aggressive than a World Health Organization (WHO) grade I neoplasm. METHODS: We identified all patients with craniopharyngioma given their diagnoses at University of California, San Francisco in a 20-year period and performed a retrospective analysis of clinicopathological and outcome characteristics. Statistical analyses were performed to determine factors that affect survival characteristics. RESULTS: Eighty patients were included in the study based on the selection criteria. Sixty-nine tumors were adamantinomatous, 9 were papillary, and 2 were unclassified. All pediatric tumors were adamantinomatous. Visual field examination in 60 patients revealed a defect in 39 and only 14 showed bitemporal field defects. Hormonal tests with abnormal results were more common in younger patients. During a median follow-up of 82 months, 38 tumors recurred. Four of 9 gross total resections and 34 of 59 subtotal resections recurred. Median time to recurrence was 16.3 months for gross total and 11.7 for subtotal resections. Progression-free survival did not differ between males and females or children and adults. There was a negative correlation between age and overall survival. CONCLUSION: Adamantinomatous craniopharyngioma is a locally aggressive neoplasm with a significant rate of recurrence. This is not in keeping with the current designation of a WHO grade I neoplasm. Subtotal resection is associated with less mortality/morbidity but a higher recurrence rate. Given the high numbers of "silent" defects, formal visual field testing should be performed in all patients with craniopharyngiomas.
BACKGROUND:Craniopharyngiomas are rare epithelial tumors that are presumed to arise from the remnants of Rathke's pouch. OBJECTIVE: This study was designed to evaluate the outcome characteristics of craniopharyngiomas treated in a single institution and to determine whether the adamantinomatous craniopharyngioma should be considered more aggressive than a World Health Organization (WHO) grade I neoplasm. METHODS: We identified all patients with craniopharyngioma given their diagnoses at University of California, San Francisco in a 20-year period and performed a retrospective analysis of clinicopathological and outcome characteristics. Statistical analyses were performed to determine factors that affect survival characteristics. RESULTS: Eighty patients were included in the study based on the selection criteria. Sixty-nine tumors were adamantinomatous, 9 were papillary, and 2 were unclassified. All pediatric tumors were adamantinomatous. Visual field examination in 60 patients revealed a defect in 39 and only 14 showed bitemporal field defects. Hormonal tests with abnormal results were more common in younger patients. During a median follow-up of 82 months, 38 tumors recurred. Four of 9 gross total resections and 34 of 59 subtotal resections recurred. Median time to recurrence was 16.3 months for gross total and 11.7 for subtotal resections. Progression-free survival did not differ between males and females or children and adults. There was a negative correlation between age and overall survival. CONCLUSION:Adamantinomatous craniopharyngioma is a locally aggressive neoplasm with a significant rate of recurrence. This is not in keeping with the current designation of a WHO grade I neoplasm. Subtotal resection is associated with less mortality/morbidity but a higher recurrence rate. Given the high numbers of "silent" defects, formal visual field testing should be performed in all patients with craniopharyngiomas.
Authors: Mohammed A Fouda; R Michael Scott; Karen J Marcus; Nicole Ullrich; Peter E Manley; Mark W Kieran; Liliana C Goumnerova Journal: Childs Nerv Syst Date: 2019-07-10 Impact factor: 1.475
Authors: Mohammed A Fouda; David Zurakowski; R Michael Scott; Karen J Marcus; Peter E Manley; Nicole J Ullrich; Laurie E Cohen; Liliana C Goumnerova Journal: Childs Nerv Syst Date: 2020-09-04 Impact factor: 1.475
Authors: Josephine R Coury; Brittany N Davis; Christoforos P Koumas; Giovanna S Manzano; Amir R Dehdashti Journal: Neurosurg Rev Date: 2018-04-17 Impact factor: 3.042
Authors: Aaron J Clark; Tene A Cage; Derick Aranda; Andrew T Parsa; Peter P Sun; Kurtis I Auguste; Nalin Gupta Journal: Childs Nerv Syst Date: 2012-10-23 Impact factor: 1.475
Authors: Luis Alberto Ortega-Porcayo; Juan Antonio Ponce-Gómez; Mauricio Martínez-Moreno; Lesly Portocarrero-Ortíz; Martha Lilia Tena-Suck; Juan Luis Gómez-Amador Journal: Int J Surg Case Rep Date: 2015-01-08
Authors: Jie Wu; Xiao Wu; You Qing Yang; Han Ding; Le Yang; You Yuan Bao; Lin Zhou; Chen Xing Yang; Tao Hong Journal: Neurosurg Rev Date: 2021-06-22 Impact factor: 2.800